A detailed history of Rangeley Capital, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Rangeley Capital, LLC holds 27,073 shares of LVTX stock, worth $41,421. This represents 0.04% of its overall portfolio holdings.

Number of Shares
27,073
Holding current value
$41,421
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$1.08 - $1.4 $29,238 - $37,902
27,073 New
27,073 $35.7 Million

Others Institutions Holding LVTX

About LAVA Therapeutics NV


  • Ticker LVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,797,700
  • Market Cap $39.5M
  • Description
  • LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...
More about LVTX
Track This Portfolio

Track Rangeley Capital, LLC Portfolio

Follow Rangeley Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rangeley Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rangeley Capital, LLC with notifications on news.